APA استشهاد

Chen, E., Brown, D. M., Wong, T. P., Benz, M. S., Kegley, E., Cox, J., . . . Kim, R. Y. (2010). Lucentis(®) using Visudyne(®) study: Determining the threshold-dose fluence of verteporfin photodynamic therapy combined with intravitreal ranibizumab for exudative macular degeneration. Dove Medical Press.

استشهاد بنمط شيكاغو

Chen, Eric, David M. Brown, Tien P. Wong, Matthew S. Benz, Eric Kegley, Joel Cox, Richard H. Fish, و Rosa Y. Kim. Lucentis(®) Using Visudyne(®) Study: Determining the Threshold-dose Fluence of Verteporfin Photodynamic Therapy Combined With Intravitreal Ranibizumab for Exudative Macular Degeneration. Dove Medical Press, 2010.

MLA استشهاد

Chen, Eric, et al. Lucentis(®) Using Visudyne(®) Study: Determining the Threshold-dose Fluence of Verteporfin Photodynamic Therapy Combined With Intravitreal Ranibizumab for Exudative Macular Degeneration. Dove Medical Press, 2010.

تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.